Synthesis of novel 3-aryl isoindolinone derivatives

Chen-ming Hu , Lian-you Zheng , Ya-zhong Pei , Xu Bai

Chemical Research in Chinese Universities ›› 2013, Vol. 29 ›› Issue (3) : 487 -494.

PDF
Chemical Research in Chinese Universities ›› 2013, Vol. 29 ›› Issue (3) : 487 -494. DOI: 10.1007/s40242-013-2294-5
Article

Synthesis of novel 3-aryl isoindolinone derivatives

Author information +
History +
PDF

Abstract

A library of novel 3-aryl isoindolinone derivatives with aromatic amino acid derivative fragments was designed and synthesized. Two synthetic routes were employed to construct 3-aryl isoindolinone ring system for different amino acid derivatives.

Keywords

Molecular library / 3-Aryl isoindolinone / Aromatic amino acid derivative

Cite this article

Download citation ▾
Chen-ming Hu, Lian-you Zheng, Ya-zhong Pei, Xu Bai. Synthesis of novel 3-aryl isoindolinone derivatives. Chemical Research in Chinese Universities, 2013, 29(3): 487-494 DOI:10.1007/s40242-013-2294-5

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Kondo T, Yoshida K, Yoshimura Y, Tanayama S. Biopharm. Drug Dispos., 1995, 16(9): 755.

[2]

Linden M, Hadler D, Hofmann S. Human Psychopharmacology: Clinical and Experimental, 1997, 12(5): 445.

[3]

Stuk T L, Assink B K, Bates R C, Erdman D T, Fedij V, Jennings S M, Lassig J A, Smith R J, Smith T L. Organic Process Research & Development, 2003, 7(6): 851.

[4]

Belliotti T R, Brink W A, Kesten S R, Rubin J R, Wustrow D J, Zoski K T, Whetzel S Z, Corbin A E, Pugsley T A, Heffner T G, Wise L D. Bioorganic & Medicinal Chemistry Letters, 1998, 8(12): 1499.

[5]

Zhuang Z P, Kung M P, Mu M, Kung H F. J. Medicinal Chemistry, 1998, 41(2): 157.

[6]

Kanamitsu N, Osaki T, Itsuji Y, Yoshimura M, Tsujimoto H, Soga M. Chemical & Pharmaceutical Bulletin, 2007, 55(12): 1682.

[7]

Bernstein P R, Aharony D, Albert J S, Andisik D, Barthlow H G, Bialecki R, Davenport T, Dedinas R F, Dembofsky B T, Koether G, Kosmider B J, Kirkland K, Ohnmacht C J, Potts W, Rumsey W L, Shen L, Shenvi A, Sherwood S, Stollman D, Russell K. Bioorganic & Medicinal Chemistry Letters, 2001, 11(20): 2769.

[8]

Mertens A, Zilch H, Koenig B, Schaefer W, Poll T, Kampe W, Seidel H, Leser U, Leinert H. J. Medicinal Chemistry, 1993, 36(17): 2526.

[9]

Brooklyn V K, Oreland E A G, Danbury S R M, Germering L W. Isoindolone Compounds, Compositions Containing the Same, and Methods of Use Thereof for the Treatment of Viral Infections Related to the Etiology of Cancer US7705021, 2010.

[10]

Wacker D A, Varnes J G, Malmstrom S E, Cao X, Hung C P, Ung T, Wu G, Zhang G, Zuvich E, Thomas M A, Keim W J, Cullen M J, Rohrbach K W, Qu Q, Narayanan R, Rossi K, Janovitz E, Lehman-McKeeman L, Malley M F, Devenny J, Pelleymounter M A, Miller K J, Robl J A. Journal of Medicinal Chemistry, 2007, 50(6): 1365.

[11]

Annika B, Jonas B, Oejvind D, Hans E, Ulrik G, Tommy I, Johan K, Roine O, Lars S, Gert S, Johan S, Yuan Z Q. Isoindoline Derivatives for the Treatment of Arrhythmias, WO 2008008022, 2008.

[12]

Honma T, Hayashi K, Aoyama T, Hashimoto N, Machida T, Fukasawa K, Iwama T, Ikeura C, Ikuta M, Suzuki-Takahashi I, Iwasawa Y, Hayama T, Nishimura S, Morishima H. J. Medicinal Chemistry, 2001, 44(26): 4615.

[13]

Hardcastle I R, Ahmed S U, Atkins H, Farnie G, Golding B T, Griffin R J, Guyenne S, Hutton C, Kaellblad P, Kemp S J, Kitching M S, Newell D R, Norbedo S, Northen J S, Reid R J, Saravanan K, Willems H M G, Lunec J. J. Medicinal Chemistry, 2006, 49(21): 6209.

[14]

Hardcastle I R, Liu J, Valeur E, Watson A, Ahmed S U, Blackburn T J, Bennaceur K, Clegg W, Drummond C, Endicott J A, Golding B T, Griffin R J, Gruber J, Haggerty K, Harrington R W, Hutton C, Kemp S, Lu X, McDonnell J M, Newell D R, Noble M E M, Payne S L, Revill C H, Riedinger C, Xu Q, Lunec J. J. Medicinal Chemistry, 2011, 54(5): 1233.

[15]

Watson A F, Liu J, Bennaceur K, Drummond C J, Endicott J A, Golding B T, Griffin R J, Haggerty K, Lu X, McDonnell J M, Newell D R, Noble M E M, Revill C H, Riedinger C, Xu Q, Zhao Y, Lunec J, Hardcastle I R. Bioorganic & Medicinal Chemistry Letters, 2011, 21(19): 5916.

[16]

Ghosh U, Bhattacharyya R, Keche A. Tetrahedron, 2010, 66(12): 2148.

[17]

Mi H Y, Cui L L, Zhang Q L, Li F, Jiang T, Liang Y T, Wang E S. Chem. Res. Chinese Universities, 2011, 27(4): 614.

[18]

David F, Robert R. Parallel Synthesis of Anticancer, Antiinflammatory, and Antiviral Agents Derived from L- and D-amino Acids, 2008, Boca Raton: CRC Press 177.

[19]

Romanova N N, Tallo T G, Rybalko I I, Zyk N V, Shvyadas V K. Chemistry of Heterocyclic Compounds, 2011, 47(4): 395.

[20]

Deniau E, Enders D. Tetrahedron Letters, 2000, 41(14): 2347.

[21]

Mamouni A, Pigeon P, Daïch A, Decroix B. Journal of Heterocyclic Chemistry, 1997, 34(5): 1495.

[22]

Allin S M, Northfield C J, Page M I, Slawin A M Z. Tetrahedron Letters, 1999, 40(1): 143.

[23]

Allin S M, Northfield C J, Page M I, Slawin A M Z. J. Chemical Society, Perkin Trans. 1, 2000, 1715.

[24]

Deniau E, Enders D, Couture A, Grandclaudon P. Tetrahedron: Asymmetry, 2003, 14(15): 2253.

[25]

Ruan Y P, Chen M D, He M Z, Zhou X, Huang P Q. Synthetic Communications, 2004, 34(5): 853.

[26]

Chen M D, Zhou X, He M Z, Ruan Y P, Huang P Q. Tetrahedron, 2004, 60(7): 1651.

[27]

Chen M D, He M Z, Zhou X, Huang L Q, Ruan Y P, Huang P Q. Tetrahedron, 2005, 61(5): 1335.

[28]

Chen M W, Chen Q A, Duan Y, Ye Z S, Zhou Y G. Chemical Communications(Cambridge, U. K.), 2012, 48(11): 1698.

[29]

Osante I, Lete E, Sotomayor N. Tetrahedron Letters, 2004, 45(6): 1253.

[30]

Wakchaure P B, Easwar S, Puranik V G, Argade N P. Tetrahedron, 2008, 64(8): 1786.

[31]

Wang E C, Chen H F, Feng P K, Lin Y L, Hsu M K. Tetrahedron Letters, 2002, 43(50): 9163.

[32]

Maity A K, Roy S. J. Organic Chemistry, 2012, 77(6): 2935.

[33]

Enders D, Braig V, Raabe G. Canadian Journal of Chemistry-revue Canadienne De Chimie, 2001, 79(11): 1528.

[34]

Campbell J B, Dedinas R F, Trumbower-Walsh S. Synlett., 2010, 3008.

[35]

Clayden J, Turnbull R, Pinto I. Tetrahedron: Asymmetry, 2005, 16(13): 2235.

[36]

Wang Z Q, Feng C G, Xu M H, Lin G Q. J. Am. Chem. Soc., 2007, 129(17): 5336.

[37]

Lamblin M, Couture A, Deniau E, Grandclaudon P. Tetrahedron: Asymmetry, 2008, 19(1): 111.

[38]

Lorion M, Couture A, Deniau E, Grandclaudon P. Synthesis, 2009, 1897.

[39]

Nguyen T B, Wang Q, Guéritte F. Chemistry: A European Journal, 2011, 17(35): 9576.

[40]

He X. Design and Synthesis of Novel Cholesterol Absorption Inhibitors, 2010, Changchun: Jilin University.

[41]

Ravi Kumar A, Bhaskar G, Madhan A, Venkateswara R B. Synthetic Communications, 2003, 33(16): 2907.

[42]

O’Brien P A, Osborne S D, Parker D. J. Chemical Society, Perkin Trans. 1, 1998, 2519.

[43]

Nieto S, Sayago F J, Laborda P, Soler T, Cativiela C, Urriolabeitia E P. Tetrahedron, 2011, 67(23): 4185.

[44]

Drandarov K, Guggisberg A, Hesse M. Helv. Chim. Acta, 2002, 85(4): 979.

[45]

Hart D J, Kanai K, Thomas D G, Yang T K. J. Organic Chemistry, 1983, 48(3): 289.

[46]

Stilz H U, Guba W, Jablonka B, Just M, Klingler O, König W, Wehner V, Zoller G. J. Medicinal Chemistry, 2001, 44(8): 1158.

AI Summary AI Mindmap
PDF

155

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/